TRT & Wound Healing: A Complex Picture

Written by Adam Maggio | Medically reviewed by Dr. Mitchell Ross, MD, ABAARM

TRT's effect on wound healing is complex; low testosterone can impair it, but supraphysiological levels might also delay repair. Careful monitoring and balancing are crucial for optimal outcomes.

TRT and Wound Healing: A Complex Picture

The influence of Testosterone Replacement Therapy (TRT) on wound healing is a topic that presents a complex and sometimes contradictory picture in medical literature. While testosterone is vital for overall tissue health, its direct role in the kinetics of wound repair is not always straightforward, and clinical nuance is essential.

Testosterone plays a crucial role in maintaining tissue integrity and promoting protein synthesis, which are fundamental processes for wound repair. Low testosterone levels, or hypogonadism, have been identified as a systemic risk factor that can impair wound healing in men. This is particularly relevant in chronic wound scenarios, where suboptimal hormonal environments can delay recovery. For instance, studies suggest that men with primary and secondary hypogonadism may experience poorer wound outcomes (Longwolf et al., 2023).

However, the relationship is not simply linear. Some research indicates that supraphysiological levels of testosterone, or even physiological levels in certain contexts, can paradoxically delay wound healing. Studies in preclinical models have shown that testosterone can impair wound healing by altering the homeostatic balance of re-epithelialization and granulation, potentially through an enhanced inflammatory response (Ashcroft et al., 2002). This suggests a delicate balance where too little or too much testosterone might be detrimental.

The mechanism behind this dual effect is thought to involve the androgen receptor. While androgen receptor activation is necessary for many anabolic processes, its over-activation in the wound bed might lead to an exaggerated inflammatory response or altered cellular proliferation patterns that impede efficient closure. Unlike the clear benefits of testosterone on muscle growth, where higher physiological levels generally correlate with better outcomes, wound healing appears to have an optimal range that can be disrupted by extremes.

A notable distinction can be drawn between the effects of testosterone on acute versus chronic wounds, and also between different tissue types. For example, while some studies suggest a potential for delayed cutaneous wound healing, other research, particularly involving the testosterone analog oxandrolone, has shown anti-catabolic and wound-healing effects in severe burn injuries (Demling & Orgill, 2000). This highlights that the context of the wound and the specific androgen involved can significantly influence the outcome.

Furthermore, the conversion of testosterone to estrogen (estradiol) also plays a role, as estrogens are generally considered pro-healing. The balance between androgens and estrogens in the local wound environment can be critical. This complexity means that simply increasing testosterone levels may not always translate to improved wound healing, and in some cases, might even be counterproductive.

In clinical practice, when a patient on TRT presents with a non-healing wound, we first ensure their testosterone levels are within a healthy physiological range, avoiding supraphysiological peaks. We also consider other factors like nutrition, infection, and underlying comorbidities. For example, a 68-year-old diabetic patient with a chronic foot ulcer and low testosterone might see improved healing with TRT, but only if his blood sugar is also well-controlled and local wound care is optimized. Conversely, a healthy young man on high-dose TRT for performance enhancement might experience delayed healing from a surgical incision, necessitating a temporary reduction in his testosterone dose.

The practical takeaway is that while optimizing testosterone levels can support overall tissue health and may aid wound healing in hypogonadal men, TRT is not a primary wound-healing agent. If you are on TRT and experience delayed wound healing, or if you have a significant wound and are considering TRT, a thorough discussion with your physician is paramount. They can assess your individual hormonal status, wound characteristics, and overall health to ensure the most appropriate management strategy, balancing the benefits of TRT with optimal wound care.